News

AddToAny

Google+ Facebook Twitter Twitter

The key players in liver regeneration

Even if up to 70% of the human liver is removed, the remaining tissue can regrow a full-sized liver within months.

Taking advantage of this regenerative capability could give more options for treating chronic liver disease.

Massachusetts Institute of Technology (MIT) engineers have created a new liver tissue model that allows them to trace the steps involved in liver regeneration more precisely than has been possible before.

The model can yield information that couldn’t be gleaned from studies of mice or other animals.

“For years, people have been identifying different genes that seem to be involved in mouse liver regeneration, and some of them seem to be important in humans, but they have never managed to figure out all of the cues to make human liver cells proliferate,” says Sangeeta Bhatia, Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science at MIT.

The study identified one molecule that appears to play a key role, and several other candidates that the researchers plan to explore further.

bit.ly/3Nqcnkv

Image credit | Shutterstock 
 

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top